Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

September 16, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Evidence found of a viral epidemic 25000 years back

World Microbiome Day

AI predicts the relation between viruses and mammals

Evidence found of a viral epidemic 25000 years back
  • BiotechToday
  • World

Evidence found of a viral epidemic 25000 years back

bioxone June 27, 2021June 26, 2021

Hari Krishnan R, SRM Institute of Science and Technology

SARS-CoV (2002), MERS-CoV (2006), and ongoing SARS-CoV2 (2019) are a few of the most devastating pandemics in history. All of these were caused by Coronaviruses. A recent study has identified a possible ancient coronavirus epidemic that happened around 20,000 years ago in East Asia regions. This is linked to a selection event that caused the adaptation of virus interacting proteins. These virus-interacting proteins (VIPs) are usually those that play a role in the host defense by interacting with the virus. Using various evolutionary tools, it was predicted that this event happened due to selection pressure in the ancient East Asia populations.

Covid-interacting proteins (CoV-VIPs)

An international study performed by a group of scientists aimed to find out whether coronavirus epidemics in the past have caused adaptation of virus-interacting proteins (VIPs). VIPs have a more functional impact on viruses than any other protein. They analyzed around 420 VIPs that are coronavirus specific from 26 human populations using data from a 1000 genomes project. Out of the 420 VIPs, 332 are SARS-CoV2 interacting proteins identified by mass spectrometry, and the other 88 are from other coronavirus family viruses. 

Evidence of a viral epidemic 25000 years ago

Evolutionary analysis showed evidence of a strong selective sweep signal (the selection that drives fixation of a beneficial mutant in a population) at CoV-VIPs. These were only observed in East Asia populations (China, Korea, Japan, Mongolia, etc.), suggesting that a previous coronavirus-related epidemic prompted an adaptation event in East Asian ancestors. Further, they identified 42 CoV-VIPs that have come under positive selection events from around 25000 years (~900 generations) that exhibit an adaptive response. 50% of these 42 CoV-VIPs were found to have high anti-viral or pro-viral activities, which supported the claim that this selection event likely happened due to a viral epidemic. 

They also infer that these adaptive mutations are found near the regulatory variants in lungs and other tissues infected by COVID-19. British cohorts were used to evaluate the SARS-CoV-2 susceptibility and it was found that the selected 42 VIPs were thought to contribute to the COVID-19 aetiology of the modern British population. This is important because four genes -SMAD3, IMPDH2, PPIB, and GPX1- that are a part of the CoV-VIPs are potential drug targets and there are ongoing clinical trials to investigate their therapeutic efficiency. These four genes are targeted by a set of eleven drugs. Further, five additional CoV-VIPs are targeted by multiple drugs for the treatment of various COVID-19 symptoms. An additional six genes are also called “druggable genomes” and are potential candidates for drug development.

Significance of the study

Exploring ancient viral pandemics can help us understand how different human populations adapt to specific genes that helped them combat viruses. It is also implied that specific human populations with adaptation do not necessarily have a difference in genetic susceptibility to the normal populations. Despite the availability of modern technology in biomedical and healthcare, COVID-19 has emphasized the vulnerability of human populations and studies like these can help us identify and understand viruses that caused pandemics and may cause pandemics in the future. Eventually, these data would help us to identify dangerous viruses and give us a head start for developing vaccines and diagnostics against them.

Also read: Nanodecoys from special lung cells can kill SARS-CoV2

Source:-

  1. Souilmi, Y., Lauterbur, M. E., Tobler, R., Huber, C. D., Johar, A. S., Moradi, S. V., Johnston, W. A., Krogan, N. J., Alexandrov, K., & Enard, D. (2021). An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia. Current Biology. Published. https://doi.org/10.1016/j.cub.2021.05.067 
  2. Staff, S. X. (2021, June 24). Genome study reveals East Asian coronavirus epidemic 20,000 years ago. Phys.Org. https://phys.org/news/2021-06-genome-reveals-east-asian-coronavirus.html
  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

About the Author- Hari Krishnan is a research enthusiast in Cell biology and Cell signalling. He is currently a final year Biotechnology Engineering student. He is a prolific Scientific writer with vast knowledge in diverse backgrounds of biotechnology. He is constantly focused on improving his knowledge and laboratory skills through various internships. A Chennai native, Hari is a spicy food lover and passionate about music and sports.

Publications-

  1. Krishnan, H. (2021). COMPARISON OF THE DRUG ENTRAPMENT EFFICIENCY OF ALMOND GUM (Badam Pisin) TO SPAN-60 NIOSOMES BY FOLIN- CIOCALTEU ASSAY. BioRxiv. https://doi.org/10.1101/2021.04.03.438312 
  2. Krishnan, H. (2020). TELOMERASE TARGETING IN CANCER. International Research Journal of Modernization in Engineering Technology and Science. https://doi.org/10.3390/cancers12082260   

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged adaptation Ancient East Asia epidemic Evolution Selection Sweep Signal VIP

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

AI predicts the relation between viruses and mammals

BioTech Today June 27, 2021

Agrima Bhatt, Rajasthan University The history of human civilization has shown evidence in the recent past that pandemics are no longer a threat for the future, with much more accessibility to hosts and ease for transfer, pandemics are creating a travesty sooner rather than later. At the end of December 2019 was the onset of […]

Related Post

  • BiotechToday
  • World

Chronic Fatigue Syndrome: Post-exertional Malaise studies

bioxone September 28, 2020September 28, 2020

BISWADEEP SEN, AMITY UNIVERSITY KOLKATA Persistent fatigue, increasing exercise intolerance, cognitive difficulties, or joint pain are the main symptoms of Post-exertional malaise. It is the pivotal reason for ME /Chronic Fatigue Syndrome. 43 patients were subjected to a Cardiopulmonary exercise test and the data was categorized systematically for analysis. In CPET, the patients have to […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

COVID-19 vaccine for children: Pfizer shows progress!

BioTech Today November 22, 2021November 22, 2021

Ananya Ghosal, MAKAUT(WB) COVID-19 vaccine is still a dream for children under 12. Although children are not at risk of COVID-19 like adults, their reports are still positive. The delta variant and reopening of schools combined and resulted in a keen rise in pediatric COVID-19 cases that is related to the records in the pandemic. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Linked read sequencing reveals the ecological resilience of a human gut microbial community during antibiotic treatment

bioxone December 14, 2020December 14, 2020

Souradip Mallick, National Institute of Technology, Rourkela The gastrointestinal metagenome is aggregation of all the genomes of gut microbiota. The gut flora is established after birth, by which time the intestinal epithelium and the intestinal mucosal barrier that it secretes developed its tolerance and also provides a barrier to pathogenic organisms. The relationship between gut flora and humans is not merely commensal but rather a mutualistic  relationship. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy